{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:15:09Z","timestamp":1789578909156,"version":"build-2803163510"},"reference-count":66,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"4","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2022,4]]},"abstract":"<jats:p>The precise contributions of histopathologic features in the determination of stage and prognosis in small intestinal neuroendocrine tumors (NETs) are still under debate, particularly as they pertain to primary tumor size, mesenteric tumor deposits (TDs), and number of regional lymph nodes with metastatic disease. This single-institution series reviewed 162 patients with small bowel NETs (84 females, mean age: 60.3\u00b112.0\u2009y). All cases examined (100%) were immunoreactive for both chromogranin A and synaptophysin. Primary tumor size &gt;1\u2009cm (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.048; odds ratio [OR]=3.06, 95% confidence interval [CI]: 1.01-9.24) and lymphovascular invasion (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.007; OR=4.85, 95% CI: 1.53-15.40) were associated with the presence of lymph node metastasis. Conversely, TDs (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.041; OR=2.73, 95% CI: 1.04-7.17) and higher pT stage (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.006; OR=4.33, 95% CI: 1.53-12.28) were associated with the presence of distant metastasis (pM). A cutoff of \u22657 positive lymph nodes was associated with pM (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.041), and a thusly defined modified pN stage (pNmod) significantly predicted pM (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.024), compared with the prototypical pN (cutoff of \u226512 positive lymph nodes), which did not. Over a median follow-up of 35.7 months, higher pNmod (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.014; OR=2.15, 95% CI: 1.16-3.96) and pM (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001; OR=11.00, 95% CI: 4.14-29.20) were associated with disease progression. Proportional hazards regression showed that higher pNmod (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.020; hazard ratio=1.51, 95% CI: 1.07-2.15) and pM (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001; hazard ratio=5.48, 95% CI: 2.90-10.37) were associated with worse progression-free survival. Finally, Kaplan-Meier survival analysis demonstrated that higher pNmod (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.003), pM (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001), and overall stage group (<jats:italic toggle=\"yes\">P<\/jats:italic>&lt;0.001) were associated with worse progression-free survival, while higher pM also predicted worse disease-specific survival (<jats:italic toggle=\"yes\">P<\/jats:italic>=0.025). These data support requiring either chromogranin or synaptophysin, but not both, for small bowel NET diagnosis, the current inclusion of a 1\u2009cm cutoff in primary tumor size and the presence of TDs in staging guidelines, and would further suggest lowering the cutoff number of positive lymph nodes qualifying for pN2 to 7 (from 12).<\/jats:p>","DOI":"10.1097\/pas.0000000000001808","type":"journal-article","created":{"date-parts":[[2021,10,23]],"date-time":"2021-10-23T01:58:28Z","timestamp":1634954308000},"page":"547-556","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":6,"title":["Evaluation of Pathologic Prognostic Factors in Neuroendocrine Tumors of the Small Intestine"],"prefix":"10.1097","volume":"46","author":[{"given":"Alexandros D.","family":"Polydorides","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qingqing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2021,10,20]]},"reference":[{"key":"R2-20250612","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1001\/jamaoncol.2017.0589","article-title":"Trends in the incidence, prevalence, and survival outcomes in patients with neuroendocrine tumors in the United States","volume":"3","author":"Dasari","year":"2017","journal-title":"JAMA Oncol"},{"key":"R3-20250612","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1111\/j.1572-0241.2007.01185.x","article-title":"A three-decade analysis of 3911 small intestinal neuroendocrine tumors: the rapid pace of no progress","volume":"102","author":"Modlin","year":"2007","journal-title":"Am J Gastroenterol"},{"key":"R4-20250612","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/his.13975","article-title":"The 2019 WHO classification of tumours of the digestive system","volume":"76","author":"Nagtegaal","year":"2020","journal-title":"Histopathology"},{"key":"R6-20250612","doi-asserted-by":"crossref","first-page":"471","DOI":"10.3322\/caac.21493","article-title":"Gastroenteropancreatic neuroendocrine tumors","volume":"68","author":"Cives","year":"2018","journal-title":"CA Cancer J Clin"},{"key":"R7-20250612","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1097\/MPA.0000000000000911","article-title":"Is multifocality an indicator of aggressive behavior in small bowel neuroendocrine tumors?","volume":"46","author":"Choi","year":"2017","journal-title":"Pancreas"},{"key":"R8-20250612","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.1016\/S1470-2045(13)70362-0","article-title":"Recommendations for management of patients with neuroendocrine liver metastases","volume":"15","author":"Frilling","year":"2014","journal-title":"Lancet Oncol"},{"key":"R9-20250612","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/cncr.11105","article-title":"A 5-decade analysis of 13,715 carcinoid tumors","volume":"97","author":"Modlin","year":"2003","journal-title":"Cancer"},{"key":"R10-20250612","first-page":"1267","article-title":"Update on surgical management of small bowel neuroendocrine tumors","volume":"38","author":"Moris","year":"2018","journal-title":"Anticancer Res"},{"key":"R11-20250612","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1007\/s00268-011-1296-z","article-title":"Long-term results of surgery for small intestinal neuroendocrine tumors at a tertiary referral center","volume":"36","author":"Norlen","year":"2012","journal-title":"World J Surg"},{"key":"R12-20250612","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1200\/JCO.2007.15.4377","article-title":"One hundred years after \u201ccarcinoid\u201d: epidemiology of and prognostic factors for neuroendocrine tumors in 35,825 cases in the United States","volume":"26","author":"Yao","year":"2008","journal-title":"J Clin Oncol"},{"key":"R13-20250612","doi-asserted-by":"crossref","first-page":"3207","DOI":"10.1245\/s10434-018-6676-2","article-title":"The distal predilection of small bowel neuroendocrine tumors","volume":"25","author":"Keck","year":"2018","journal-title":"Ann Surg Oncol"},{"key":"R14-20250612","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1159\/000365143","article-title":"Well-differentiated neuroendocrine neoplasia: relapse-free survival and predictors of recurrence after curative intended resections","volume":"90","author":"Dieckhoff","year":"2014","journal-title":"Digestion"},{"key":"R15-20250612","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/j.1477-2574.2010.00198.x","article-title":"Long-term survival after surgical management of neuroendocrine hepatic metastases","volume":"12","author":"Glazer","year":"2010","journal-title":"HPB (Oxford)"},{"key":"R16-20250612","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.dld.2011.04.021","article-title":"Relapse factors for ileal neuroendocrine tumours after curative surgery: a retrospective French multicentre study","volume":"43","author":"Le Roux","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R17-20250612","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1159\/000443170","article-title":"ENETS consensus guidelines update for neuroendocrine neoplasms of the jejunum and ileum","volume":"103","author":"Niederle","year":"2016","journal-title":"Neuroendocrinology"},{"key":"R18-20250612","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1177\/000313481708301033","article-title":"Prognostic factors associated with outcomes in small bowel neuroendocrine tumors","volume":"83","author":"Manguso","year":"2017","journal-title":"Am Surg"},{"key":"R19-20250612","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1002\/jso.25657","article-title":"Prognostic factors influencing survival in small bowel neuroendocrine tumor with liver metastases","volume":"120","author":"Manguso","year":"2019","journal-title":"J Surg Oncol"},{"key":"R21-20250612","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1038\/modpathol.2013.232","article-title":"Should mesenteric tumor deposits be included in staging of well-differentiated small intestine neuroendocrine tumors?","volume":"27","author":"Gonzalez","year":"2014","journal-title":"Mod Pathol"},{"key":"R22-20250612","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1038\/s41379-020-0585-1","article-title":"Diagnosis and prognostic significance of extramural venous invasion in neuroendocrine tumors of the small intestine","volume":"33","author":"Liu","year":"2020","journal-title":"Mod Pathol"},{"issue":"suppl 4","key":"R23-20250612","doi-asserted-by":"crossref","first-page":"S356","DOI":"10.1016\/S1590-8658(11)60591-4","article-title":"Gastroenteropancreatic (neuro)endocrine neoplasms: the histology report","volume":"43","author":"Rindi","year":"2011","journal-title":"Dig Liver Dis"},{"key":"R24-20250612","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000369275","article-title":"Grading of neuroendocrine neoplasms: mitoses and Ki-67 are both essential","volume":"100","author":"van Velthuysen","year":"2014","journal-title":"Neuroendocrinology"},{"key":"R25-20250612","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1002\/(SICI)1097-0142(19970315)79:6<1086::AID-CNCR5>3.0.CO;2-E","article-title":"Carcinoids of the jejunum and ileum: an immunohistochemical and clinicopathologic study of 167 cases","volume":"79","author":"Burke","year":"1997","journal-title":"Cancer"},{"key":"R26-20250612","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00268-020-05884-6","article-title":"Prognostic factors in curative resected locoregional small intestine neuroendocrine neoplasms","volume":"45","author":"Evers","year":"2021","journal-title":"World J Surg"},{"key":"R27-20250612","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1007\/s00268-013-1918-8","article-title":"Resection of at-risk mesenteric lymph nodes is associated with improved survival in patients with small bowel neuroendocrine tumors","volume":"37","author":"Landry","year":"2013","journal-title":"World J Surg"},{"key":"R28-20250612","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/1097-0142(196109\/10)14:5<901::AID-CNCR2820140502>3.0.CO;2-Q","article-title":"Life history of the carcinoid tumor of the small intestine","volume":"14","author":"Moertel","year":"1961","journal-title":"Cancer"},{"key":"R29-20250612","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1007\/s11605-017-3524-9","article-title":"Optimal lymphadenectomy in small bowel neuroendocrine tumors: analysis of the NCDB","volume":"22","author":"Motz","year":"2018","journal-title":"J Gastrointest Surg"},{"key":"R30-20250612","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1002\/jso.20179","article-title":"Prognostic indicators for carcinoid neuroendocrine tumors of the gastrointestinal tract","volume":"89","author":"Rorstad","year":"2005","journal-title":"J Surg Oncol"},{"key":"R31-20250612","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1097\/00000658-199906000-00008","article-title":"Prognosis and survival in patients with gastrointestinal tract carcinoid tumors","volume":"229","author":"Shebani","year":"1999","journal-title":"Ann Surg"},{"key":"R32-20250612","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1080\/00365520903082432","article-title":"Small intestinal neuroendocrine tumors: prognostic factors and survival","volume":"44","author":"Bergestuen","year":"2009","journal-title":"Scand J Gastroenterol"},{"key":"R33-20250612","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1007\/BF01658532","article-title":"Surgical treatment of mid-gut carcinoid tumors","volume":"14","author":"Makridis","year":"1990","journal-title":"World J Surg"},{"key":"R34-20250612","first-page":"353","article-title":"Carcinoids of the small intestine: a statistical evaluation of 1102 cases collected from the literature","volume":"16","author":"Soga","year":"1997","journal-title":"J Exp Clin Cancer Res"},{"key":"R35-20250612","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.humpath.2016.05.023","article-title":"Ileal \u201ccarcinoid\u201d tumors-small size belies deadly intent: high rate of nodal metastasis in tumors <\/=1 cm in size","volume":"56","author":"Walsh","year":"2016","journal-title":"Hum Pathol"},{"key":"R36-20250612","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1097\/MPA.0000000000001526","article-title":"A predictive nomogram for small intestine neuroendocrine tumors","volume":"49","author":"Kelly","year":"2020","journal-title":"Pancreas"},{"key":"R37-20250612","first-page":"322","article-title":"Carcinoid tumours. Frequency in a defined population during a 12-year period","volume":"84","author":"Berge","year":"1976","journal-title":"Acta Pathol Microbiol Scand A"},{"key":"R38-20250612","doi-asserted-by":"crossref","first-page":"1560","DOI":"10.1038\/s41379-018-0075-x","article-title":"Number, not size, of mesenteric tumor deposits affects prognosis of small intestinal well-differentiated neuroendocrine tumors","volume":"31","author":"Gonzalez","year":"2018","journal-title":"Mod Pathol"},{"key":"R39-20250612","first-page":"647","article-title":"The frequency of gastrointestinal endocrine tumours in a well-defined population\u2014Northern Ireland 1970-1985","volume":"72","author":"Watson","year":"1989","journal-title":"Q J Med"},{"key":"R40-20250612","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1097\/00000478-200306000-00013","article-title":"Solitary versus multiple carcinoid tumors of the ileum: a clinical and pathologic review of 68 cases","volume":"27","author":"Yantiss","year":"2003","journal-title":"Am J Surg Pathol"},{"key":"R41-20250612","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1159\/000371807","article-title":"Prognostic significance of lymph node metastases in small intestinal neuroendocrine tumors","volume":"101","author":"Kim","year":"2015","journal-title":"Neuroendocrinology"},{"key":"R42-20250612","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000491017","article-title":"The lymph node ratio optimizes staging in patients with small intestinal neuroendocrine tumors","volume":"107","author":"Wu","year":"2018","journal-title":"Neuroendocrinology"},{"key":"R43-20250612","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1001\/jamasurg.2018.3865","article-title":"Prognostic role of lymph node positivity and number of lymph nodes needed for accurately staging small-bowel neuroendocrine tumors","volume":"154","author":"Zaidi","year":"2019","journal-title":"JAMA Surg"},{"key":"R44-20250612","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s00428-017-2258-0","article-title":"Ki67 labeling index: assessment and prognostic role in gastroenteropancreatic neuroendocrine neoplasms","volume":"472","author":"Kloppel","year":"2018","journal-title":"Virchows Arch"},{"key":"R45-20250612","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00428-007-0452-1","article-title":"TNM staging of midgut and hindgut (neuro) endocrine tumors: a consensus proposal including a grading system","volume":"451","author":"Rindi","year":"2007","journal-title":"Virchows Arch"},{"key":"R46-20250612","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S0046-8177(98)90206-4","article-title":"Immunohistologic analysis of gastrointestinal and pulmonary carcinoid tumors","volume":"29","author":"Al-Khafaji","year":"1998","journal-title":"Hum Pathol"},{"key":"R47-20250612","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1309\/UKN6PVRKXHG422DA","article-title":"Usefulness of CDX2 and TTF-1 in differentiating gastrointestinal from pulmonary carcinoids","volume":"123","author":"Saqi","year":"2005","journal-title":"Am J Clin Pathol"},{"key":"R48-20250612","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1097\/01.pas.0000135527.96318.20","article-title":"Neuroendocrine secretory protein-55 (NESP-55) expression discriminates pancreatic endocrine tumors and pheochromocytomas from gastrointestinal and pulmonary carcinoids","volume":"28","author":"Srivastava","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"R49-20250612","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/ajcp\/86.4.415","article-title":"Gastroenteropancreatic neuroendocrine tumors. A histochemical and immunohistochemical study of epithelial (keratin proteins, carcinoembryonic antigen) and neuroendocrine (neuron-specific enolase, bombesin and chromogranin) markers in foregut, midgut, and hindgut tumors","volume":"86","author":"Nash","year":"1986","journal-title":"Am J Clin Pathol"},{"key":"R50-20250612","doi-asserted-by":"crossref","first-page":"181","DOI":"10.5858\/134.2.181","article-title":"Protocol for the examination of specimens from patients with neuroendocrine tumors (carcinoid tumors) of the small intestine and ampulla","volume":"134","author":"Washington","year":"2010","journal-title":"Arch Pathol Lab Med"},{"key":"R51-20250612","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1186\/s12885-017-3490-3","article-title":"Clinicopathological features and prognostic validity of WHO grading classification of SI-NENs","volume":"17","author":"Chen","year":"2017","journal-title":"BMC Cancer"},{"key":"R52-20250612","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/EC-16-0114","article-title":"Predicting the survival of patients with small bowel neuroendocrine tumours: comparison of 3 systems","volume":"6","author":"Clift","year":"2017","journal-title":"Endocr Connect"},{"key":"R53-20250612","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1159\/000486097","article-title":"Prognostic factors for survival among patients with small bowel neuroendocrine tumours associated with mesenteric desmoplasia","volume":"106","author":"Laskaratos","year":"2018","journal-title":"Neuroendocrinology"},{"key":"R54-20250612","first-page":"2912361","article-title":"Prognostic factors and survival time in patients with small bowel tumors: a retrospective observational study","volume":"2019","author":"Taghipour Zahir","year":"2019","journal-title":"Int J Surg Oncol"},{"key":"R55-20250612","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1002\/cncr.20939","article-title":"Early-stage carcinoids of the gastrointestinal tract: an analysis of 1914 reported cases","volume":"103","author":"Soga","year":"2005","journal-title":"Cancer"},{"key":"R56-20250612","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/his.13771","article-title":"Should Ki67 immunohistochemistry be performed on all lesions in multifocal small intestinal neuroendocrine tumours?","volume":"74","author":"Numbere","year":"2019","journal-title":"Histopathology"},{"key":"R57-20250612","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/PAS.0000000000000751","article-title":"Mesenteric tumor deposits in midgut small intestinal neuroendocrine tumors are a stronger indicator than lymph node metastasis for liver metastasis and poor prognosis","volume":"41","author":"Fata","year":"2017","journal-title":"Am J Surg Pathol"},{"key":"R58-20250612","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/MPA.0000000000000846","article-title":"The surgical management of small bowel neuroendocrine tumors: consensus guidelines of the North American Neuroendocrine Tumor Society","volume":"46","author":"Howe","year":"2017","journal-title":"Pancreas"},{"key":"R59-20250612","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1159\/000493317","article-title":"Evaluation of clinical prognostic factors and further delineation of the effect of mesenteric fibrosis on survival in advanced midgut neuroendocrine tumours","volume":"107","author":"Laskaratos","year":"2018","journal-title":"Neuroendocrinology"},{"key":"R60-20250612","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/PAS.0000000000001225","article-title":"Impact of peritoneal metastasis on survival of patients with small intestinal neuroendocrine tumor","volume":"43","author":"Wright","year":"2019","journal-title":"Am J Surg Pathol"},{"key":"R61-20250612","doi-asserted-by":"crossref","first-page":"3776","DOI":"10.1200\/JCO.2013.51.1477","article-title":"Revised staging classification improves outcome prediction for small intestinal neuroendocrine tumors","volume":"31","author":"Kim","year":"2013","journal-title":"J Clin Oncol"},{"key":"R62-20250612","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s12022-015-9371-x","article-title":"Breast metastasis as the first clinical manifestation of ileal neuroendocrine tumor. A challenging diagnosis with relevant clinical implications","volume":"26","author":"La Rosa","year":"2015","journal-title":"Endocr Pathol"},{"key":"R63-20250612","doi-asserted-by":"crossref","first-page":"e14989","DOI":"10.1097\/MD.0000000000014989","article-title":"A case report on metastatic ileal neuroendocrine neoplasm to the breast masquerading as primary breast cancer: a diagnostic challenge and management dilemma","volume":"98","author":"Papalampros","year":"2019","journal-title":"Medicine (Baltimore)"},{"key":"R64-20250612","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00268-013-2037-2","article-title":"Metastases from neuroendocrine tumors to the breast are more common than previously thought. A diagnostic pitfall?","volume":"37","author":"Crona","year":"2013","journal-title":"World J Surg"},{"key":"R65-20250612","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.clinimag.2016.10.011","article-title":"Metastatic carcinoid tumor to the breast: report of two cases and review of the literature","volume":"42","author":"Lee","year":"2017","journal-title":"Clin Imaging"},{"key":"R66-20250612","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/PAP.0b013e3182a2dc67","article-title":"Assigning site of origin in metastatic neuroendocrine neoplasms: a clinically significant application of diagnostic immunohistochemistry","volume":"20","author":"Bellizzi","year":"2013","journal-title":"Adv Anat Pathol"},{"key":"R67-20250612","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/j.surg.2014.08.008","article-title":"A practical method to determine the site of unknown primary in metastatic neuroendocrine tumors","volume":"156","author":"Maxwell","year":"2014","journal-title":"Surgery"},{"key":"R68-20250612","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s00428-021-03085-7","article-title":"An algorithmic approach utilizing CK7, TTF1, beta-catenin, CDX2, and SSTR2A can help differentiate between gastrointestinal and pulmonary neuroendocrine carcinomas","volume":"479","author":"Yu","year":"2021","journal-title":"Virchows Arch"},{"key":"R69-20250612","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1001\/archsurg.142.3.229","article-title":"Small-bowel tumors: epidemiologic and clinical characteristics of 1260 cases from the Connecticut Tumor Registry","volume":"142","author":"Hatzaras","year":"2007","journal-title":"Arch Surg"}],"container-title":["American Journal of Surgical Pathology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001808","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,12]],"date-time":"2025-06-12T17:00:38Z","timestamp":1749747638000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/PAS.0000000000001808"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,20]]},"references-count":66,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022]]}},"URL":"https:\/\/doi.org\/10.1097\/pas.0000000000001808","relation":{},"ISSN":["0147-5185"],"issn-type":[{"value":"0147-5185","type":"print"}],"subject":[],"published":{"date-parts":[[2021,10,20]]}}}